Atlassian (NASDAQ:TEAM) Director Scott Farquhar Sells 7,665 Shares

Atlassian Corporation PLC (NASDAQ:TEAM) Director Scott Farquhar sold 7,665 shares of the stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $172.79, for a total transaction of $1,324,435.35. Following the completion of the sale, the director directly owned 306,600 shares in the company, valued at approximately $52,977,414. The trade was a 2.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Scott Farquhar also recently made the following trade(s):

• On Friday, October 31st, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $167.61, for a total transaction of $1,284,730.65.
• On Wednesday, October 29th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $160.41, for a total transaction of $1,229,542.65.
• On Monday, October 27th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $165.03, for a total transaction of $1,264,954.95.
• On Friday, October 24th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $164.50, for a total transaction of $1,260,892.50.
• On Wednesday, October 22nd, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $169.16, for a total transaction of $1,296,611.40.
• On Friday, October 17th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $151.21, for a total transaction of $1,159,024.65.
• On Monday, October 20th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $157.28, for a total transaction of $1,205,551.20.
• On Wednesday, October 15th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $151.83, for a total transaction of $1,163,776.95.
• On Monday, October 13th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $147.81, for a total transaction of $1,132,963.65.
• On Friday, October 10th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $145.85, for a total transaction of $1,117,940.25.

Atlassian Stock Down 6.3%

NASDAQ:TEAM traded down $11.08 during trading hours on Tuesday, hitting $165.00. The stock had a trading volume of 4,898,819 shares, compared to its average volume of 2,499,999. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.73. Atlassian Corporation PLC has a 1-year low of $144.32 and a 1-year high of $326.00. The business has a 50 day simple moving average of $164.24 and a two-hundred day simple moving average of $187.56. The company has a market cap of $43.28 billion, a PE ratio of -232.39 and a beta of 0.95.

Atlassian (NASDAQ:TEAM) last issued its quarterly earnings data on Thursday, October 30th. The technology company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.21. Atlassian had a negative net margin of 3.38% and a negative return on equity of 7.20%. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.40 billion. During the same quarter last year, the company earned $0.77 earnings per share. Atlassian’s revenue for the quarter was up 20.6% on a year-over-year basis. Atlassian has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts predict that Atlassian Corporation PLC will post -0.34 EPS for the current year.

Institutional Investors Weigh In On Atlassian

A number of hedge funds and other institutional investors have recently modified their holdings of TEAM. Capco Asset Management LLC acquired a new position in Atlassian during the second quarter worth about $25,000. Physician Wealth Advisors Inc. grew its stake in Atlassian by 60.4% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after acquiring an additional 61 shares in the last quarter. Atlantic Union Bankshares Corp grew its stake in Atlassian by 19,900.0% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock valued at $32,000 after acquiring an additional 199 shares in the last quarter. Smithfield Trust Co grew its stake in Atlassian by 90.7% during the 1st quarter. Smithfield Trust Co now owns 164 shares of the technology company’s stock valued at $34,000 after acquiring an additional 78 shares in the last quarter. Finally, Geneos Wealth Management Inc. grew its stake in Atlassian by 447.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock valued at $42,000 after acquiring an additional 161 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

TEAM has been the subject of a number of recent analyst reports. Robert W. Baird set a $230.00 price target on shares of Atlassian in a research report on Friday. Barclays decreased their price target on shares of Atlassian from $244.00 to $215.00 and set an “overweight” rating for the company in a research report on Friday, August 8th. Stephens decreased their price target on shares of Atlassian from $221.00 to $202.00 and set an “equal weight” rating for the company in a research report on Monday, August 11th. Truist Financial set a $210.00 price target on shares of Atlassian in a research report on Friday. Finally, Wells Fargo & Company started coverage on shares of Atlassian in a research report on Tuesday, September 30th. They set an “overweight” rating and a $216.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Atlassian presently has a consensus rating of “Moderate Buy” and a consensus price target of $239.44.

About Atlassian

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.